Compare ASMB & LSBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ASMB | LSBK |
|---|---|---|
| Founded | 2005 | 1891 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Savings Institutions |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 512.1M | 135.5M |
| IPO Year | 2010 | 2025 |
| Metric | ASMB | LSBK |
|---|---|---|
| Price | $29.82 | $18.74 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $44.20 | N/A |
| AVG Volume (30 Days) | ★ 321.1K | 12.0K |
| Earning Date | 05-06-2026 | 04-22-2026 |
| Dividend Yield | N/A | ★ 2.27% |
| EPS Growth | ★ 91.78 | 49.23 |
| EPS | N/A | ★ 0.56 |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $638.39 | N/A |
| P/E Ratio | ★ N/A | $33.20 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $20.23 | $12.50 |
| 52 Week High | $39.71 | $18.85 |
| Indicator | ASMB | LSBK |
|---|---|---|
| Relative Strength Index (RSI) | 43.60 | 86.15 |
| Support Level | $25.86 | $17.01 |
| Resistance Level | $30.62 | N/A |
| Average True Range (ATR) | 1.74 | 0.27 |
| MACD | -0.55 | 0.16 |
| Stochastic Oscillator | 1.80 | 92.27 |
Assembly Biosciences Inc is a clinical-stage biotechnology company. The Company's pipeline includes multiple clinical-stage investigational therapies, including: (1) two long-acting helicase-primase inhibitors (HPI) for the treatment of recurrent genital herpes; (2) an orally bioavailable hepatitis delta virus entry inhibitor; and (3) a potent next-generation capsid assembly modulator designed to disrupt the replication cycle of hepatitis B virus (HBV) at several key points. The Company's pipeline also includes a novel, oral broad-spectrum non-nucleoside polymerase inhibitor (NNPI) for the treatment of transplant-related herpesviruses.
Lake Shore Bancorp Inc operates as a savings and loan holding company. The bank's business consists of attracting retail deposits from the general public in the areas surrounding its branch offices and investing those deposits, together with funds generated from operations, in commercial real estate loans, one-to-four family residential mortgage loans, home equity lines of credit, and, to a lesser extent, commercial business loans, consumer loans, and investment securities. Its revenues are principally derived from interest earned on loans and investment securities.